Gene · 54
Papers2,683
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 2,683
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A 10-month cluster-randomized trial to shift towards plant-forward meals in early childhood education and care centres: effects on bone and mineral metabolism in Finnish children. | Eur J Nutr | 2026 | 42489936 | PubTator, text mining | PubMed |
| PFOA promotes PMAIP1-MCL1 apoptotic vulnerability within a BHLHE41-associated macrophage regulatory architecture in atherosclerosis. | Chem Biol Interact | 2026 | 42486287 | PubTator, text mining | PubMed |
Association between bone turnover markers and bone mineral density after 12 months of exercise in patients with chronic kidney disease stages 3-5: a post-hoc exploratory sub-study of the RENEXC randomized controlled trial. | J Nephrol | 2026 | 42479427 | PubTator, text mining | PubMed |
| Serum activin A and bone metabolism in patients undergoing hemodialysis. | Osteoporos Int | 2026 | 42463974 | PubTator, text mining | PubMed |
| A Multicenter Integrative Cohort Characterizing the Genetic, Clinical, and Transcriptomic Features of ACP5 Deficiency. | Arthritis Rheumatol | 2026 | 42459138 | PubTator, text mining | PubMed |
| HR-pQCT measures of bone in autosomal dominant osteopetrosis highly correlate with fractures and inversely correlate with bone resorption markers. | J Bone Miner Res | 2026 | 42436644 | PubTator, text mining | PubMed |
| Inflammation mediated Osteoclastogenesis and bone resorption markers in Periodontitis subjects with and without type 2 diabetes- A Cross-sectional study. | J Oral Biol Craniofac Res | 2026 | 42434496 | PubTator, text mining | PubMed |
| Homocysteine and bone metabolism markers in osteoporotic patients: A secondary analysis. | Medicine (Baltimore) | 2026 | 42432934 | PubTator, text mining | PubMed |
| Increased Skeletal Parathyroid Hormone Responsiveness and Risk of Decreased Lumbar Bone Mineral Density in Patients Receiving Chronic Hemodialysis: A 5-Year, Retrospective, Longitudinal Study. | Ther Apher Dial | 2026 | 42423218 | PubTator, text mining | PubMed |
| Effects of Antiresorptive Treatment on Bone Mineral Density and Bone Turnover Markers in a Child With Steroid-Resistant Nephrotic Syndrome: A Case Report. | Nephrology (Carlton) | 2026 | 42409586 | PubTator, text mining | PubMed |
| On-treatment change in bone turnover markers predicts 2-year bone mineral density after sequential therapy following romosozumab: a real-world cohort study. | Front Endocrinol (Lausanne) | 2026 | 42388877 | PubTator, text mining | PubMed |
| Prune Consumption and Bone Health in Older Men: A One-Year Randomized Controlled Trial. | Nutrients | 2026 | 42356242 | PubTator, text mining | PubMed |
| Nutritional Status Is Associated with Bone Mineral Density, Vitamin D Levels, and Bone Turnover Markers in Patients with Proximal Femoral Fragility Fractures: A Retrospective Observational Study. | Medicina (Kaunas) | 2026 | 42356105 | PubTator, text mining | PubMed |
| Combination of Biomarkers and Novel Diagnostic Tools in the Management of Osteoporosis in Chronic Kidney Disease: An Update. | J Clin Med | 2026 | 42355880 | PubTator, text mining | PubMed |
| Long-term longitudinal changes in bone matrix and turnover markers in rheumatoid arthritis: A retrospective cohort study. | Medicine (Baltimore) | 2026 | 42332458 | PubTator, text mining | PubMed |
| The Proteomic Profile of Adults With a Fontan Circulation. | JACC Adv | 2026 | 42312768 | PubTator, text mining | PubMed |
| Efficacy of romosozumab followed by denosumab in glucocorticoid users; a randomized clinical trial. | Osteoporos Int | 2026 | 42301302 | PubTator, text mining | PubMed |
| Siglec-15 binds mucin-domain glycoproteins with extended glycans and marks an osteoclast-like, matrix remodeling myeloid state in human tumors. | Glycobiology | 2026 | 42286920 | PubTator, text mining | PubMed |
| Genetic landscape of early-onset systemic lupus erythematous in India. | Rheumatology (Oxford) | 2026 | 42251732 | PubTator, text mining | PubMed |
| Osteoporosis in long-term hospitalized patients with muscular dystrophy: a retrospective cross-sectional study. | BMC Musculoskelet Disord | 2026 | 42243771 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54/papers?page=2